- Home
- IVDA vs CVKD Comparison
IVDA vs CVKD Comparison
Compare IVDA & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- CVKD
- Stock Information
- Founded
- IVDA 2003
- CVKD 2022
- Country
- IVDA United States
- CVKD United States
- Employees
- IVDA N/A
- CVKD N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- IVDA Technology
- CVKD Health Care
- Exchange
- IVDA Nasdaq
- CVKD Nasdaq
- Market Cap
- IVDA 3.5M
- CVKD 17.1M
- IPO Year
- IVDA N/A
- CVKD 2023
- Fundamental
- Price
- IVDA $1.64
- CVKD $14.45
- Analyst Decision
- IVDA
- CVKD Strong Buy
- Analyst Count
- IVDA 0
- CVKD 2
- Target Price
- IVDA N/A
- CVKD $52.50
- AVG Volume (30 Days)
- IVDA 40.0K
- CVKD 59.6K
- Earning Date
- IVDA 11-20-2024
- CVKD 11-08-2024
- Dividend Yield
- IVDA N/A
- CVKD N/A
- EPS Growth
- IVDA N/A
- CVKD N/A
- EPS
- IVDA N/A
- CVKD N/A
- Revenue
- IVDA $3,779,754.00
- CVKD N/A
- Revenue This Year
- IVDA $23.76
- CVKD N/A
- Revenue Next Year
- IVDA $229.89
- CVKD N/A
- P/E Ratio
- IVDA N/A
- CVKD N/A
- Revenue Growth
- IVDA N/A
- CVKD N/A
- 52 Week Low
- IVDA $1.40
- CVKD $5.40
- 52 Week High
- IVDA $10.16
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- IVDA 41.96
- CVKD 56.80
- Support Level
- IVDA $1.40
- CVKD $11.19
- Resistance Level
- IVDA $1.72
- CVKD $17.95
- Average True Range (ATR)
- IVDA 0.10
- CVKD 1.37
- MACD
- IVDA 0.06
- CVKD 0.10
- Stochastic Oscillator
- IVDA 75.00
- CVKD 49.64
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc is engaged in offering real-time IP video surveillance technologies. The company provides IoT sensors and devices for various applications such as energy management, smart homes, smart buildings, smart communities, and patients and eldercare. Its IvedaAI provides AI functions to IP cameras and network video recorders and video management systems. The group has a business presence in the U.S. and the Republic of China (Taiwan), from which key revenue is derived from the Republic of China (Taiwan).
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.